Cheng-Hung Chiang1, Wei-Chun Huang2, Jin-Shiou Yang3, Chin-Chang Cheng4, Feng-Yu Kuo5, Kuan-Rau Chiou4, Tao-Yu Lee5, Tzu-Wen Lin6, Guang-Yuan Mar5, Chuen-Wang Chiou4, Chun-Peng Liu4, King-Teh Lee7. 1. Cardiovascular Medical Center, Kaohsiung Veterans General Hospital; ; Graduate Institute of Healthcare Administration, Kaohsiung Medical University, Kaohsiung; 2. Cardiovascular Medical Center, Kaohsiung Veterans General Hospital; ; School of Medicine, National Yang-Ming University, Taipei; ; Department of Physical Therapy, Fooyin University; 3. Department of Physical Therapy, Fooyin University; 4. Cardiovascular Medical Center, Kaohsiung Veterans General Hospital; ; School of Medicine, National Yang-Ming University, Taipei; 5. Cardiovascular Medical Center, Kaohsiung Veterans General Hospital; 6. Cheng Shiu University; 7. Graduate Institute of Healthcare Administration, Kaohsiung Medical University, Kaohsiung; ; Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Abstract
BACKGROUND: Diabetes mellitus (DM) is a strong risk factor of cardiovascular disease. To date, the impact of DM on outcomes after acute myocardial infarction (AMI) in Taiwan is undetermined. The aim of this study was to compare five-year outcomes after AMI in patients with and without diabetes in Taiwan. METHODS: A nationwide cohort of 25,028 diabetic and 56,028 non-diabetic patients who were first hospitalized with AMI between 1996 and 2005 was enrolled through linkage with the Taiwan National Health Insurance research database. Patient mortality rates within 30 days after AMI, and 1, 3, and 5 years thereafter were compared. RESULTS: Length of hospital stay (8.9 ± 8.7 vs. 8.2 ± 8.0 days, p < 0.01) and medical cost during admission (in Taiwan dollars: $129,123 ± $158,073 vs. $121,631 ± $157,018, p < 0.01) were significantly higher in diabetic patients. The difference in mortality rate within 30 days was insignificant between diabetic and non-diabetic patients (18.1% vs. 17.6%, p = 0.06). Mortalities within 1 year (31.0% vs. 26.8%, p < 0.01), 3 years (42.4% vs. 34.7%, p < 0.01), and 5 years (50.6% vs. 41.1%, p < 0.01) were significantly higher in diabetic patients. In patients with AMI who underwent percutaneous coronary intervention (PCI) during index admission, the mortality rate within 30 days was insignificant (6.3% vs. 6.4%, p = 0.70) but mortalities within 1 year (15.2% vs. 11.6%, p < 0.01), 3 years (24.1% vs. 17.2%, p < 0.01), and 5 years (32.2% vs. 22.6%, p < 0.01) were significantly higher in diabetic patients. CONCLUSIONS: The average patient length of hospital stay and medical cost during admission were significantly higher in diabetic patients. Additionally, the difference in mortality rate within 30 days after AMI was insignificant between diabetic and non-diabetic patients. Also, long-term mortality after AMI was significantly higher in diabetic patients. KEY WORDS: Acute myocardial infarction; Diabetes mellitus; Length of hospital stay; Medical cost; Mortality; National health insurance.
BACKGROUND:Diabetes mellitus (DM) is a strong risk factor of cardiovascular disease. To date, the impact of DM on outcomes after acute myocardial infarction (AMI) in Taiwan is undetermined. The aim of this study was to compare five-year outcomes after AMI in patients with and without diabetes in Taiwan. METHODS: A nationwide cohort of 25,028 diabetic and 56,028 non-diabeticpatients who were first hospitalized with AMI between 1996 and 2005 was enrolled through linkage with the Taiwan National Health Insurance research database. Patient mortality rates within 30 days after AMI, and 1, 3, and 5 years thereafter were compared. RESULTS: Length of hospital stay (8.9 ± 8.7 vs. 8.2 ± 8.0 days, p < 0.01) and medical cost during admission (in Taiwan dollars: $129,123 ± $158,073 vs. $121,631 ± $157,018, p < 0.01) were significantly higher in diabeticpatients. The difference in mortality rate within 30 days was insignificant between diabetic and non-diabeticpatients (18.1% vs. 17.6%, p = 0.06). Mortalities within 1 year (31.0% vs. 26.8%, p < 0.01), 3 years (42.4% vs. 34.7%, p < 0.01), and 5 years (50.6% vs. 41.1%, p < 0.01) were significantly higher in diabeticpatients. In patients with AMI who underwent percutaneous coronary intervention (PCI) during index admission, the mortality rate within 30 days was insignificant (6.3% vs. 6.4%, p = 0.70) but mortalities within 1 year (15.2% vs. 11.6%, p < 0.01), 3 years (24.1% vs. 17.2%, p < 0.01), and 5 years (32.2% vs. 22.6%, p < 0.01) were significantly higher in diabeticpatients. CONCLUSIONS: The average patient length of hospital stay and medical cost during admission were significantly higher in diabeticpatients. Additionally, the difference in mortality rate within 30 days after AMI was insignificant between diabetic and non-diabeticpatients. Also, long-term mortality after AMI was significantly higher in diabeticpatients. KEY WORDS: Acute myocardial infarction; Diabetes mellitus; Length of hospital stay; Medical cost; Mortality; National health insurance.
Authors: Matthew B Kahn; Richard M Cubbon; Ben Mercer; Alison C G Wheatcroft; Guy Gherardi; Amir Aziz; Vivek Baliga; Jonathan M Blaxill; Jim M McLenachan; Daniel J Blackman; John P Greenwood; Stephen B Wheatcroft Journal: Diab Vasc Dis Res Date: 2011-11-08 Impact factor: 3.291
Authors: Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith Journal: Circulation Date: 2011-03-28 Impact factor: 29.690
Authors: Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Jacqueline E Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao Journal: Circulation Date: 2012-12-17 Impact factor: 29.690
Authors: Harlan M Krumholz; Yun Wang; Jersey Chen; Elizabeth E Drye; John A Spertus; Joseph S Ross; Jeptha P Curtis; Brahmajee K Nallamothu; Judith H Lichtman; Edward P Havranek; Frederick A Masoudi; Martha J Radford; Lein F Han; Michael T Rapp; Barry M Straube; Sharon-Lise T Normand Journal: JAMA Date: 2009-08-19 Impact factor: 56.272
Authors: Mariusz Gąsior; Damian Pres; Marek Gierlotka; Michał Hawranek; Grzegorz Słonka; Andrzej Lekston; Paweł Buszman; Zbigniew Kalarus; Marian Zembala; Lech Poloński Journal: Kardiol Pol Date: 2012 Impact factor: 3.108
Authors: José Carlos Nicolau; Carlos Vicente Serrano; Roberto Rocha Giraldez; Luciano Moreira Baracioli; Humberto Graner Moreira; Felipe Lima; Marcelo Franken; Roberto Kalil; José Antonio Franchini Ramires; Robert P Giugliano Journal: Diabetes Care Date: 2011-10-25 Impact factor: 19.112